Authors

Latest:

Advice for Community Physicians Treating Patients with Neuroendocrine Tumor-Associated Carcinoid Syndrome

Drs Das, Pommier, and Zacks share their advice for community physicians treating patients who have neuroendocrine tumors with carcinoid syndrome and carcinoid heart disease.

Lance Baldo, M.D., Chief Medical Officer, Adaptive Biotechnologies Sponsored Content by Adaptive Biotechnologies

Latest:

NGS MRD Testing in Blood Cancer Is Needed Now More Than Ever

Sponsored Content by Ipsen Biopharmaceuticals, Inc.

Latest:

Finding Common Ground: Considerations for Making Treatment Decisions in R/R Follicular Lymphoma

Minsig Choi, MD, Stony Brook University Hospital

Latest:

Optimizing Treatment Strategies in R/R Hepatocellular Carcinoma

Shai Friedland, MD

Latest:

Dr. Friedland on a Multimodal Screening Blood Test to Detect CRC

Shai Friedland, MD, discusses a multimodal screening blood test for advanced adenomas in colorectal cancer.

Katherine Walsh, MD

Latest:

Preparing and Delivering a Virtual Learning Session

Strategies are important to optimize learning in the virtual environment including speaker preparation, creating a virtual learning climate, and encouraging and enhancing interaction.

Courtney R. Arn, APRN-CNP

Latest:

Advice for New Nurse Practitioners Working With Patients With Endometrial Cancer

Closing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.

Cristina Saura Manich, MD, PhD

Latest:

Dr Manich on the ReDiscover Study of RLY-2608 in PIK3CA-Mutant Advanced Solid Tumors

Cristina Saura Manich, MD, PhD, discusses the phase 1 ReDiscover study evaluating RLY-2608 in patients with PIK3CA-mutated advanced breast cancer and other solid tumors.

Andrew J. Wagner, MD, PhD

Latest:

Wagner on the Investigation of Nab-Sirolimus in Advanced Malignant PEComa

Dr Wagner discusses unmet needs for patients with PEComa, ongoing research to address these gaps, and findings from the AMPECT trial.

Cara A. Mathews, MD

Latest:

Dr Mathews on Maintenance Olaparib in Ovarian Cancer

Cara A. Mathews, MD, discusses 7-year overall survival data from the phase 3 SOLO-1 trial in patients with ovarian cancer.

Srikala Sridhar, MD, MSc, FRCPC

Latest:

Dr Sridhar on the Use of Zelenectide Pevedotin in Locally Advanced or Metastatic Urothelial Cancer

Srikala Sridhar, MD, MSc, FRCPC, discusses the unique application of zelenectide pevedotin, which targets nectin-4 in locally advanced or metastatic urothelial cancer.

Pashna Munshi, MD

Latest:

Current Treatment Options for Patients with Steroid-Refractory Acute GVHD

Closing her discussion, Dr Pashna Munshi reviews recent data on the available treatment options for patients with steroid-refractory acute GVHD.

Madhurima Anne, MD

Latest:

Dr. Anne on the Practice-Changing Data of DESTINY-Breast04 in HER2-Low Breast Cancer

Madhurima Anne, MD, discusses the practice-changing data of the phase 3 DESTINY-Breast04 trial in patients with HER2-low breast cancer.

David L. Porter, MD, University of Pennsylvania

Latest:

Back to the Future: How New and Emerging Trends in CAR T-Cell Therapy Can Affect Your Patients

Sarah Sewaralthahab, MD, MPH

Latest:

Trainees Deserve Better Feedback

Feedback plays a key role in medical edu-cation and faculty development as it allows everyone to evaluate their performance and improve their intrapersonal skills.

Ayesha Alvero, MD, MSc

Latest:

Dr Alvero on Antitumor Immunological Memory in Ovarian Cancer Models

Ayesha Alvero, MD, MSc, discusses findings from a preclinical study investigating the antitumor effects and recurrence prevention abilities of a virus-like vesicle thought to establish immunological memory in mouse models with ovarian cancer.

Laura W. Dillon, PhD, FACMG

Latest:

Ongoing Research on MRD Detection May Shift Outcomes for Posttransplant AML

The prediction of relapse following treatment with allogeneic stem cell transplant in patients with acute myeloid leukemia in first complete remission remains an unmet need due to limitations attributed to measurable residual disease detection methods.

Justin Kaner, MD

Latest:

Menin Inhibitors for AML: A Roundtable on the Latest Advances

Justin Kaner, MD, discusses the latest advances surrounding menin inhibitors in acute myeloid leukemia.

Ryan Scott

Ryan Scott joined MJH Life Sciences in 2021. In addition to writing and editing timely news and article coverage, she manages

Latest:

Study Reveals Subgroups of Patients With RCC Who May Have Durable Responses to Immunotherapy: With David A. Braun, MD, PhD

Dr Braun discusses molecular factors that contribute to exceptional immune checkpoint inhibition responses among patients with renal cell carcinoma.

asey M. Cosgrove, MD

Latest:

Dr Cosgrove on T-DXd Treatment in Ovarian Cancer

Casey M. Cosgrove, MD, discusses treatment with the ADC T-DXd in patients with ovarian cancer.